MEDsan

MEDsan is a German biotechnology company based in Hamburg that specializes in the development and manufacture of diagnostic solutions and regenerative therapies. As a subsidiary of the SAN Group, the company rose to prominence as a leading manufacturer of high-sensitivity SARS-CoV-2 rapid antigen tests and PCR diagnostics during the global pandemic. Beyond infectious disease testing, MEDsan is heavily invested in the field of regenerative medicine, focusing on the therapeutic potential of mesenchymal stem cells (MSCs). Their research aims to harness MSC-derived secretomes and exosomes to treat chronic inflammatory and degenerative diseases. The company operates state-of-the-art, ISO-certified production facilities in Germany, ensuring high standards for its medical devices and biological research. MEDsan's integrated approach combines rapid diagnostic innovation with long-term biological drug development.